<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="pmc-domain-id">1692</journal-id><journal-id journal-id-type="pmc-domain">nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430434</article-id><article-id pub-id-type="pmcid-ver">PMC12430434.1</article-id><article-id pub-id-type="pmcaid">12430434</article-id><article-id pub-id-type="pmcaiid">12430434</article-id><article-id pub-id-type="doi">10.3390/nu17172779</article-id><article-id pub-id-type="publisher-id">nutrients-17-02779</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Octenyl Succinic Anhydride Starch Alleviates Alcoholic Liver Disease by Modulating Gut Microbiota and Metabolism</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0004-3979-6357</contrib-id><name name-style="western"><surname>Liu</surname><given-names initials="C">Chang</given-names></name><xref rid="af1-nutrients-17-02779" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02779" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0007-1437-8054</contrib-id><name name-style="western"><surname>Liu</surname><given-names initials="T">Tangqian</given-names></name><xref rid="af1-nutrients-17-02779" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02779" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ma</surname><given-names initials="R">Rongrong</given-names></name><xref rid="af1-nutrients-17-02779" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02779" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pan</surname><given-names initials="X">Xiaohua</given-names></name><xref rid="af1-nutrients-17-02779" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02779" ref-type="aff">2</xref><xref rid="c1-nutrients-17-02779" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tian</surname><given-names initials="Y">Yaoqi</given-names></name><xref rid="af1-nutrients-17-02779" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02779" ref-type="aff">2</xref><xref rid="af3-nutrients-17-02779" ref-type="aff">3</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Sakurai</surname><given-names initials="T">Toshihiro</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nutrients-17-02779"><label>1</label>State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China; <email>liuchang670250789@jiangnan.edu.cn</email> (C.L.); <email>1011230114@stu.jiangnan.edu.cn</email> (T.L.); <email>rrma01@jiangnan.edu.cn</email> (R.M.); <email>yqtian@jiangnan.edu.cn</email> (Y.T.)</aff><aff id="af2-nutrients-17-02779"><label>2</label>School of Food Science and Technology, Jiangnan University, Wuxi 214122, China</aff><aff id="af3-nutrients-17-02779"><label>3</label>Analysis and Testing Center, Jiangnan University, Wuxi 214122, China</aff><author-notes><corresp id="c1-nutrients-17-02779"><label>*</label>Correspondence: <email>panxiaohua@jiangnan.edu.cn</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">495755</issue-id><elocation-id>2779</elocation-id><history><date date-type="received"><day>16</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>18</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nutrients-17-02779.pdf"/><abstract><p><bold>Background/Objectives</bold>: Alcoholic liver disease (ALD) is intricately linked to gut microbiota dysbiosis and metabolic disturbances along the gut&#8211;liver axis. Octenyl succinic anhydride (OSA) starch escapes digestion in the small intestine and ferments in the colon, modulating gut microbiota and metabolism. This study explored the protective effects of OSA starch against ALD and elucidated the underlying gut microbiota&#8211;metabolite interactions. <bold>Methods:</bold> A chronic ethanol-fed mouse model was conducted to evaluate the protective effects of OSA starch against ALD, and multi-omics analyses integrating 16S rRNA sequencing, PICRUSt2 functional predictions, and metabolomics were used to reveal potential mechanism. <bold>Results</bold>: OSA starch supplementation in ALD mice significantly reduced liver fat accumulation, lowered the liver index to 4.11%, and restored serum transaminase levels closer to normal. Multi-omics analyses revealed that OSA starch enriched beneficial gut bacteria such as <italic toggle="yes">Faecalibaculum rodentium</italic> and <italic toggle="yes">Bifidobacterium adolescentis</italic>. OSA starch also enhanced microbial metabolic functions, including pyruvate, butanoate, and propanoate metabolism. These shifts were accompanied by regulation of fecal and serum metabolites, including pyruvate, 2-hydroxybutanoic acid, and lactic acid. Structural equation modeling further confirmed that OSA starch ameliorates ALD via coordinated modulation of gut microbiota, microbial functions, metabolites, and serum markers. <bold>Conclusions</bold>: OSA starch protects against alcoholic liver injury by remodeling the gut&#8211;liver metabolic network, presenting a promising dietary strategy for ALD.</p></abstract><kwd-group><kwd>OSA starch</kwd><kwd>alcoholic liver disease</kwd><kwd>gut microbiota</kwd><kwd>host metabolism</kwd></kwd-group><funding-group><award-group><funding-source>China Postdoctoral Science Foundation</funding-source><award-id>2024M761182</award-id></award-group><award-group><funding-source>Postdoctoral Fellowship Program of CPSF</funding-source><award-id>GZB20240279</award-id></award-group><award-group><funding-source>Jiangsu Funding Program for Excellent Postdoctoral Talent</funding-source><award-id>2024ZB209</award-id></award-group><funding-statement>This work is financially supported by the China Postdoctoral Science Foundation (2024M761182), Postdoctoral Fellowship Program of CPSF (No. GZB20240279), and Jiangsu Funding Program for Excellent Postdoctoral Talent (No. 2024ZB209).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-17-02779"><title>1. Introduction</title><p>Alcoholic liver disease (ALD) is a significant contributor to chronic liver injury and mortality worldwide, predominantly driven by prolonged excessive alcohol consumption [<xref rid="B1-nutrients-17-02779" ref-type="bibr">1</xref>]. The progression of ALD involves hepatic steatosis, underpinned by complex interactions between the liver and the gut [<xref rid="B2-nutrients-17-02779" ref-type="bibr">2</xref>,<xref rid="B3-nutrients-17-02779" ref-type="bibr">3</xref>]. Growing evidence highlights the gut&#8211;liver axis as a central player in ALD pathogenesis, particularly through gut microbiota dysbiosis and increased intestinal permeability [<xref rid="B4-nutrients-17-02779" ref-type="bibr">4</xref>]. These alterations facilitate the translocation of various microbial metabolites into the portal circulation, promoting hepatic steatosis and metabolic disruption. Moreover, shifts in gut-derived metabolites&#8212;such as short-chain fatty acids, amino acid derivatives, and bile acids&#8212;profoundly influence hepatic lipid metabolism, oxidative stress, and immune responses, all of which contribute to ALD progression [<xref rid="B5-nutrients-17-02779" ref-type="bibr">5</xref>]. ALD is associated with gut bacterial products and their translocation to the liver, although the role of specific microbiota changes remains unclear [<xref rid="B6-nutrients-17-02779" ref-type="bibr">6</xref>]. Therefore, nutritional interventions targeting the microbiome have emerged as a promising strategy for ALD prevention and treatment [<xref rid="B7-nutrients-17-02779" ref-type="bibr">7</xref>,<xref rid="B8-nutrients-17-02779" ref-type="bibr">8</xref>].</p><p>Among nutritional interventions, resistant starches have emerged as promising prebiotic agents capable of reshaping gut microbial communities and their metabolic outputs [<xref rid="B9-nutrients-17-02779" ref-type="bibr">9</xref>,<xref rid="B10-nutrients-17-02779" ref-type="bibr">10</xref>]. Octenyl succinic anhydride (OSA) starch, as a modified resistant starch, escapes digestion in the small intestine and undergoes fermentation in the colon by commensal bacteria, leading to the production of short-chain fatty acids like butyrate, propionate, and acetate [<xref rid="B11-nutrients-17-02779" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-17-02779" ref-type="bibr">12</xref>]. These microbial metabolites play essential roles in enhancing gut barrier integrity and regulating lipid and glucose metabolism. Additionally, resistant starch intake has been linked to favorable shifts in microbial functional pathways, such as those involved in energy metabolism, amino acid synthesis, and bile acid transformation, which collectively support host metabolic health [<xref rid="B13-nutrients-17-02779" ref-type="bibr">13</xref>,<xref rid="B14-nutrients-17-02779" ref-type="bibr">14</xref>]. OSA is a commonly used esterification agent that modifies starches, making the derivative amphiphilic and capable of acting as an emulsion stabilizer [<xref rid="B15-nutrients-17-02779" ref-type="bibr">15</xref>]. Approved as a food additive, OSA-modified starch has undergone rapid global consumption due to its beneficial properties, including reducing fat absorption in the gut by encapsulating fat particles [<xref rid="B16-nutrients-17-02779" ref-type="bibr">16</xref>]. Given that OSA starch has also been proven to have a highly similar ability to regulate the microbiota and SCFAs, this type of resistant starch may have the potential to prevent ALD. While resistant starch has shown efficacy in improving metabolic diseases like obesity and non-alcoholic fatty liver disease [<xref rid="B17-nutrients-17-02779" ref-type="bibr">17</xref>,<xref rid="B18-nutrients-17-02779" ref-type="bibr">18</xref>], OSA starch&#8217;s potential to mitigate alcohol-induced liver injury through modulation of gut microbiota and microbial metabolism remains underexplored.</p><p>In this study, the protective effects of OSA starch against ALD were systematically evaluated using a chronic alcohol-fed mouse model. Comprehensive assessments, including liver histopathology, serum biochemistry, fecal and serum metabolomics, and gut microbiota profiling via 16S rRNA gene sequencing, were conducted. Functional predictions and pathway analyses were further employed to elucidate microbial metabolic functions influenced by OSA starch. Structural equation modeling was applied to clarify the mechanistic pathways linking OSA starch, gut microbiota, microbial metabolites, and liver health. These findings underscore the potential of OSA starch as a dietary strategy for ALD.</p></sec><sec id="sec2-nutrients-17-02779"><title>2. Materials and Methods</title><sec id="sec2dot1-nutrients-17-02779"><title>2.1. Establishment of Alcoholic Liver Injury Model and Dietary OSA Starch Intervention</title><p>A total of 24 male C57BL/6J mice aged eight weeks were purchased from Gem Pharmatech Co., Ltd. (Nanjing, China) and maintained under specific pathogen-free conditions with controlled environment parameters. All animal procedures received ethical approval from the Animal Ethics Committee of Jiangnan University (JN. No 20240930c0641123), following the ARRIVE guidelines for animal research. Mice were randomly assigned to one of three experimental groups (n = 8 per group) using a random number generator to ensure unbiased group allocation: Control, Model, and OSA starch intervention groups. Both the Control and ALD Model groups were fed a standard chow containing native corn starch as the main carbohydrate source. The OSA starch group was provided with a diet where native starch was fully replaced by OSA-modified starch. The dietary formulations followed established protocols from a previous study [<xref rid="B19-nutrients-17-02779" ref-type="bibr">19</xref>].</p><p>To induce alcoholic liver damage, mice in the Model and OSA starch groups received daily oral gavage of ethanol. For the initial 27 days, 42% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) ethanol was administered, followed by a single dose of 50% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) ethanol on day 28. Ethanol dosing began at 0.1 mL per 10 g body weight in the first week, and was progressively increased to 0.15 mL/10 g from the third week onward. Control group mice were gavaged with an equivalent volume of sterile water throughout the experiment.</p></sec><sec id="sec2dot2-nutrients-17-02779"><title>2.2. Serum Biochemical Assays</title><p>Following an overnight fast, mice were anesthetized via intraperitoneal injection of 2&#8211;3% isoflurane. Blood was drawn, and liver tissues were promptly collected for further analysis. Serum was isolated by centrifugation at 3000&#215; <italic toggle="yes">g</italic> for 10 min at 4 &#176;C. Key biochemical markers, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT), and aspartate aminotransferase (AST), were quantified using a BS-350E automated biochemical analyzer (Myriad Biomedical, Shenzhen, China).</p></sec><sec id="sec2dot3-nutrients-17-02779"><title>2.3. Liver Histology via Hematoxylin and Eosin Staining</title><p>Liver specimens were fixed in 4% paraformaldehyde at room temperature for 24 h, dehydrated through a graded ethanol series, cleared with xylene, and embedded in paraffin. Paraffin blocks were sliced into 4 &#956;m sections using a rotary microtome (Leica, IL, USA). The tissue sections were then stained with hematoxylin and eosin (H&amp;E) and examined microscopically for histopathological evaluation.</p></sec><sec id="sec2dot4-nutrients-17-02779"><title>2.4. Untargeted Metabolomics Profiling</title><p>Metabolic profiling was conducted using a QTRAP 5500 mass spectrometer (AB SCIEX, Framingham, MA, USA) connected to an ultra-high-performance liquid chromatography (UHPLC) system. Both positive and negative ionization modes of electrospray ionization (ESI) were employed. For extraction, 50 &#956;L/mg of each sample was combined with 400 &#956;L of pre-cooled methanol containing internal standards. Fecal samples were processed with 2&#8211;3 stainless steel beads and homogenized using a tissue grinder (60 Hz, 15 s per cycle, 3&#8211;4 cycles) under chilled conditions. Samples were then subjected to 15 min of sonication in an ice-water bath and centrifuged at 10,000&#215; <italic toggle="yes">g</italic> for 20 min at 4 &#176;C.</p><p>Approximately 300 &#956;L of the supernatant was collected, evaporated to dryness under vacuum at low temperatures, and reconstituted in 100 &#956;L of 20% methanol. The mixture was vortexed, sonicated, and centrifuged again before being transferred to autosampler vials for UHPLC&#8211;MS/MS analysis. Chromatographic separation was carried out using a BEH C18 column (1.7 &#956;m, 2.1 &#215; 100 mm, Waters, Milford, MA, USA) with 0.1% formic acid in water as mobile phase A and acetonitrile as mobile phase B for positive mode. For negative ion mode, an HSS T3 column (1.8 &#956;m, 2.1 &#215; 100 mm, Waters, Milford, MA, USA) was utilized. The column temperature was maintained at 50 &#176;C. Data acquisition and initial analysis were performed using Analyst software 1.7.2 (AB SCIEX, Framingham, MA, USA). The identity of the metabolites was confirmed based on the MS/MS spectra, comparing the observed fragmentation patterns with available reference spectra in the database. This included matching retention times and the specific mass-to-charge values, as well as interpreting the fragmentation pathways for structural confirmation. Additionally, the metabolite analysis was further validated by comparing the results with data available on MetaboAnalyst 5.0, which provides comprehensive information on known metabolites and their fragmentation profiles [<xref rid="B20-nutrients-17-02779" ref-type="bibr">20</xref>].</p></sec><sec id="sec2dot5-nutrients-17-02779"><title>2.5. 16S rRNA Gene Sequencing and Microbial Functional Prediction</title><p>Genomic DNA from fecal samples was extracted with the TIANamp Stool DNA Kit (DP328, TIANGEN, Beijing, China), following the manufacturer&#8217;s instructions. The quality and quantity of DNA were assessed via a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) and agarose gel electrophoresis. The V3&#8211;V4 regions of the bacterial 16S rRNA gene were amplified using specific primers with Illumina adapters. Purified PCR products were quantified and pooled in equimolar amounts. Libraries were prepared using the TruSeq DNA PCR-Free Library Prep Kit (Illumina, San Diego CA, USA), and sequencing was conducted on the Illumina NovaSeq 6000 platform (paired-end, 2 &#215; 250 bp).</p><p>Raw sequences underwent quality filtering with Trimmomatic to remove adapters and low-quality reads, and merged using FLASH. Operational taxonomic units (OTUs) were clustered at 97% sequence similarity via USEARCH. Taxonomic classification was performed against the SILVA database (version 138). Microbial functional potential was predicted using PICRUSt2 to infer KEGG Orthologs (KOs) based on 16S rRNA profiles. All sequencing and computational analyses were completed by Wekemo Tech Group Co., Ltd. (Shenzhen, China).</p></sec><sec id="sec2dot6-nutrients-17-02779"><title>2.6. Statistical and Computational Analyses</title><p>Data are expressed as mean &#177; standard deviation (SD). Statistical analyses were carried out using GraphPad Prism 7.0 (GraphPad Software Inc., San Diego, CA, USA). Differences between groups were evaluated by one-way analysis of variance (ANOVA) with Dunnett&#8217;s post hoc test. A <italic toggle="yes">p</italic>-value &lt; 0.05 was considered statistically significant (* <italic toggle="yes">p</italic> &lt; 0.05). Differential microbial taxa were identified using linear discriminant analysis effect size (LEfSe) on the Galaxy platform (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://usegalaxy.org/">https://usegalaxy.org/</uri>).</p></sec></sec><sec sec-type="results" id="sec3-nutrients-17-02779"><title>3. Results and Discussion</title><sec id="sec3dot1-nutrients-17-02779"><title>3.1. OSA Starch Ameliorates Hepatic Injury and Lipid Dysregulation in ALD Mice</title><p>To evaluate the protective effects of OSA starch on ALD, a chronic alcohol feeding model in mice, together with a 28-day intervention with OSA starch, was established (<xref rid="nutrients-17-02779-f001" ref-type="fig">Figure 1</xref>A). Alcohol exposure significantly elevated the liver index, indicating hepatomegaly as a consequence of fat accumulation (<italic toggle="yes">p</italic> &lt; 0.01, <xref rid="nutrients-17-02779-f001" ref-type="fig">Figure 1</xref>B) [<xref rid="B21-nutrients-17-02779" ref-type="bibr">21</xref>]. OSA starch supplementation markedly reduced the liver index compared to the ALD Model group (<italic toggle="yes">p</italic> &lt; 0.05), suggesting mitigation of alcohol-induced liver enlargement. This reduction corresponds with a significant decrease in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels (<italic toggle="yes">p</italic> &lt; 0.01 and <italic toggle="yes">p</italic> &lt; 0.05, respectively; <xref rid="nutrients-17-02779-f001" ref-type="fig">Figure 1</xref>C,D), key biomarkers for liver injury [<xref rid="B22-nutrients-17-02779" ref-type="bibr">22</xref>]. Consistently, histological examination revealed pronounced steatosis and hepatocellular ballooning in the ALD Model group, whereas OSA starch intervention substantially alleviated these pathological features, maintaining liver architecture closer to that of controls (<xref rid="nutrients-17-02779-f001" ref-type="fig">Figure 1</xref>I). These outcomes align with prior studies indicating that dietary fibers can modulate the gut&#8211;liver axis, thereby alleviating alcohol-induced hepatic injury [<xref rid="B23-nutrients-17-02779" ref-type="bibr">23</xref>].</p><p>In parallel, alcohol exposure disrupted lipid metabolism, as reflected by elevated total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C), alongside decreased high-density lipoprotein cholesterol (HDL-C) (<xref rid="nutrients-17-02779-f001" ref-type="fig">Figure 1</xref>E&#8211;H) [<xref rid="B24-nutrients-17-02779" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-17-02779" ref-type="bibr">25</xref>]. OSA starch supplementation significantly lowered TG levels (<italic toggle="yes">p</italic> &lt; 0.05) and restored HDL-C levels (<italic toggle="yes">p</italic> &lt; 0.01), both of which are critical in mitigating the progression of steatosis and cardiovascular risk. Interestingly, OSA starch did not significantly alter TC or LDL-C levels compared to the ALD Model group. Together, these findings demonstrate that OSA starch exerts benefits on liver morphology, function, and lipid metabolism in ALD.</p></sec><sec id="sec3dot2-nutrients-17-02779"><title>3.2. OSA Starch Intervention Reshapes Gut Microbiota Composition in ALD Mice</title><p>To investigate the regulatory effects of OSA starch on gut microbial dysbiosis induced by alcohol exposure, alpha diversity and microbial community structure in ALD mice were assessed [<xref rid="B26-nutrients-17-02779" ref-type="bibr">26</xref>]. Shannon indices (<xref rid="nutrients-17-02779-f002" ref-type="fig">Figure 2</xref>A) revealed that chronic alcohol consumption increased species richness, reflecting an unstable gut microbial species [<xref rid="B27-nutrients-17-02779" ref-type="bibr">27</xref>]. Interestingly, OSA starch supplementation attenuated the ethanol-induced increase in microbial species richness, indicating a selective regulation of the microbial composition. Principal component analysis (PCA) based on Bray&#8211;Curtis distance (<xref rid="nutrients-17-02779-f002" ref-type="fig">Figure 2</xref>B) demonstrated a clear segregation of microbial profiles, with the OSA starch group distinctly clustering away from the ALD model, indicating a pronounced shift in microbial structure attributable to the dietary intervention.</p><p>At the taxonomic level, phylum-level analysis (<xref rid="nutrients-17-02779-f002" ref-type="fig">Figure 2</xref>C) showed that alcohol exposure disrupted the balance between Firmicutes and Bacteroidota. OSA starch partially restored this ratio, primarily by reducing the relative abundance of Proteobacteria, a phylum often associated with barrier dysfunction [<xref rid="B28-nutrients-17-02779" ref-type="bibr">28</xref>]. At the phylum level, alcohol exposure increased the relative abundance of Proteobacteria while decreasing Firmicutes, consistent with dysbiosis patterns commonly observed in liver injury (<xref rid="nutrients-17-02779-f002" ref-type="fig">Figure 2</xref>C) [<xref rid="B29-nutrients-17-02779" ref-type="bibr">29</xref>]. Species-level profiling (<xref rid="nutrients-17-02779-f002" ref-type="fig">Figure 2</xref>D) revealed that OSA starch increased beneficial microbes such as <italic toggle="yes">Faecalibaculum rodentium</italic> and <italic toggle="yes">Bifidobacterium adolescentis</italic>, while reducing the abundance of potentially pathogenic taxa like <italic toggle="yes">Muribaculum gordoncarteri</italic>. These compositional changes are consistent with the known prebiotic effects of resistant starches, which modulate the gut microbiota to enhance host metabolic and immune health [<xref rid="B9-nutrients-17-02779" ref-type="bibr">9</xref>,<xref rid="B30-nutrients-17-02779" ref-type="bibr">30</xref>]. Collectively, these results suggest that OSA starch ameliorates alcohol-induced gut dysbiosis through microbiome modulation.</p></sec><sec id="sec3dot3-nutrients-17-02779"><title>3.3. OSA Starch Modulates Key Gut Microbial Taxa and Their Functional Profiles in ALD Mice</title><p>Comprehensive analysis of gut microbiota alterations induced by OSA starch intervention in ALD mice revealed significant shifts in bacterial composition and diversity. LEfSe analysis identified distinct microbial biomarkers across experimental groups (<xref rid="nutrients-17-02779-f003" ref-type="fig">Figure 3</xref>A). The ALD Model group exhibited an enrichment of potentially pathogenic species such as <italic toggle="yes">Haemophilus parainfluenzae</italic>, <italic toggle="yes">Veillonella atypica</italic>, and <italic toggle="yes">Muribaculum gordoncarteri</italic>, which have been implicated in gut barrier dysfunction and inflammation [<xref rid="B31-nutrients-17-02779" ref-type="bibr">31</xref>,<xref rid="B32-nutrients-17-02779" ref-type="bibr">32</xref>]. Conversely, OSA starch supplementation selectively enriched beneficial taxa, including <italic toggle="yes">Faecalibaculum rodentium</italic>, <italic toggle="yes">Bacteroides acidifaciens</italic>, and <italic toggle="yes">Bifidobacterium adolescentis</italic>. These species are recognized as producers of short-chain fatty acids, particularly butyrate, known to reinforce intestinal integrity and exert anti-inflammatory effects, potentially contributing to the alleviation of ALD pathology [<xref rid="B23-nutrients-17-02779" ref-type="bibr">23</xref>,<xref rid="B33-nutrients-17-02779" ref-type="bibr">33</xref>,<xref rid="B34-nutrients-17-02779" ref-type="bibr">34</xref>].</p><p>Random forest classification further validated the discriminative microbial features between groups, achieving low classification error rates (<xref rid="nutrients-17-02779-f003" ref-type="fig">Figure 3</xref>B). The most influential taxa contributing to group separation, as indicated by the mean decrease in accuracy, included <italic toggle="yes">Faecalibaculum rodentium</italic>, <italic toggle="yes">Haemophilus parainfluenzae</italic>, and <italic toggle="yes">Bifidobacterium adolescentis</italic> (<xref rid="nutrients-17-02779-f003" ref-type="fig">Figure 3</xref>C). These key species are involved in metabolic pathways essential for maintaining host lipid homeostasis and modulating immune responses [<xref rid="B35-nutrients-17-02779" ref-type="bibr">35</xref>,<xref rid="B36-nutrients-17-02779" ref-type="bibr">36</xref>]. Co-occurrence network analysis (<xref rid="nutrients-17-02779-f003" ref-type="fig">Figure 3</xref>D) demonstrated that <italic toggle="yes">Bifidobacterium adolescentis</italic> and <italic toggle="yes">Faecalibaculum rodentium</italic> formed central nodes within the microbial ecosystem of OSA starch-treated mice, suggesting that OSA starch fosters a more interconnected microbial community structure.</p><p>Functional predictions based on PICRUSt2 and KEGG pathway analysis revealed that OSA starch intervention notably influenced microbial metabolic potential (<xref rid="nutrients-17-02779-f003" ref-type="fig">Figure 3</xref>E). Specifically, pathways associated with propanoate metabolism, glycolysis/gluconeogenesis, and galactose metabolism were reduced in the OSA starch group, which linked to metabolic disturbances in ALD [<xref rid="B37-nutrients-17-02779" ref-type="bibr">37</xref>]. In contrast, pathways such as glyoxylate and dicarboxylate metabolism were relatively enhanced, indicating a metabolic shift towards improved energy efficiency and substrate utilization. These microbial functional adaptations align with the biochemical improvements observed in liver function and lipid profiles, supporting the role of OSA starch in mitigating ALD progression through targeted modulation of the gut microbiome and its metabolism.</p></sec><sec id="sec3dot4-nutrients-17-02779"><title>3.4. Key Gut Microbial Metabolic Pathways Modulated by OSA Starch in ALD Mice</title><p>Functional pathway analysis based on PICRUSt2 prediction revealed that OSA starch notably regulated gut microbial metabolic functions centered on carbon metabolism, including the pyruvate, glyoxylate, and dicarboxylate, butanoate, and propanoate metabolism pathways (<xref rid="app1-nutrients-17-02779" ref-type="app">Supplementary Figure S1</xref>). In the pyruvate metabolism pathway, several critical enzymes responsible for converting pyruvate into acetyl-CoA, lactate, and other intermediates were significantly altered (<xref rid="app1-nutrients-17-02779" ref-type="app">Supplementary Figure S1A</xref>). Hepatic pyruvate metabolism is critical and complementary for maintenance of antioxidant capacity [<xref rid="B38-nutrients-17-02779" ref-type="bibr">38</xref>]. Additionally, modulation of glyoxylate and dicarboxylate metabolism suggests enhanced microbial capacity for the glyoxylate cycle (<xref rid="app1-nutrients-17-02779" ref-type="app">Supplementary Figure S1B</xref>), which is pivotal in maintaining energy efficiency under metabolic stress conditions commonly associated with liver diseases [<xref rid="B39-nutrients-17-02779" ref-type="bibr">39</xref>].</p><p>Moreover, the butanoate and propanoate metabolism pathways were distinctly influenced, as evidenced by the differential regulation of enzymes involved in the synthesis of key short-chain fatty acids, such as butyrate and propionate (<xref rid="app1-nutrients-17-02779" ref-type="app">Supplementary Figure S1C,D</xref>). Short-chain fatty acids are critical mediators of gut&#8211;liver axis health, with butyrate known to strengthen intestinal barrier integrity and propionate contributing to lipid metabolism regulation [<xref rid="B40-nutrients-17-02779" ref-type="bibr">40</xref>,<xref rid="B41-nutrients-17-02779" ref-type="bibr">41</xref>]. The attenuation of propanoate metabolism alongside the remodeling of butanoate pathways may help restore short-chain fatty acid homeostasis disrupted in ALD. This metabolic reconfiguration in the gut microbiota highlights a potential mechanism by which OSA starch exerts its protective effects against hepatic injury via microbial metabolic modulation.</p></sec><sec id="sec3dot5-nutrients-17-02779"><title>3.5. OSA Starch Reshapes Fecal Metabolome and Modulates Key Metabolic Pathways in ALD Mice</title><p>Untargeted fecal metabolomics revealed a distinct metabolic reprogramming following OSA starch intervention in ALD mice. PCA demonstrated clear separation between the Control, Model, and OSA starch groups, reflecting the overall impact of OSA starch on metabolic profiles (<xref rid="nutrients-17-02779-f004" ref-type="fig">Figure 4</xref>A). The volcano plots identified pyruvate accumulation as a hallmark of ALD progression, with the Model group showing significant decreases compared to Control (<xref rid="nutrients-17-02779-f004" ref-type="fig">Figure 4</xref>B). Conversely, OSA starch supplementation not only sustained elevated pyruvate and 2-hydroxy-butanoic acid levels but also substantially reduced the abundance of lactic acid, L-glutamic acid, beta-leucine, and creatine&#8212;metabolites linked to disrupted amino acid and energy metabolism (<xref rid="nutrients-17-02779-f004" ref-type="fig">Figure 4</xref>C). These metabolic shifts suggest that OSA starch may redirect pyruvate flux away from lactate production and abnormal amino acid turnover, promoting more efficient energy homeostasis. Further analysis using Upset plots identified metabolites converging on four pivotal metabolic pathways: pyruvate metabolism, propanoate metabolism, butanoate metabolism, and glyoxylate and dicarboxylate metabolism (<xref rid="nutrients-17-02779-f004" ref-type="fig">Figure 4</xref>D). These pathways are central to maintaining carbon flow between glycolysis, the TCA cycle, and short-chain fatty acid production [<xref rid="B42-nutrients-17-02779" ref-type="bibr">42</xref>]. The heatmap clustering emphasized the normalized metabolic landscape in the OSA starch group relative to the Model (<xref rid="nutrients-17-02779-f004" ref-type="fig">Figure 4</xref>E).</p><p>A detailed metabolite&#8211;pathway interaction network (<xref rid="nutrients-17-02779-f005" ref-type="fig">Figure 5</xref>A) mapped the relationships between these four key pathways and their representative metabolites. Pyruvate metabolism emerged as a central hub, directly connected to citrulline, ornithine, creatine, lactic acid, and beta-leucine, among others. This centrality underscores pyruvate&#8217;s critical role as a metabolic crossroad linking amino acid biosynthesis and energy production [<xref rid="B43-nutrients-17-02779" ref-type="bibr">43</xref>]. Additionally, propanoate, butanoate, and glyoxylate metabolism were interconnected through shared metabolites such as glutamine, glyceric acid, and malic acid, highlighting the intricate metabolic crosstalk restored by OSA starch intervention. KEGG enrichment analysis further revealed significant regulation of pathways involved in arginine and proline metabolism, pyruvate metabolism, histidine metabolism, and glyoxylate pathways (<xref rid="nutrients-17-02779-f005" ref-type="fig">Figure 5</xref>B), which are also relevant to hepatic and intestinal health [<xref rid="B44-nutrients-17-02779" ref-type="bibr">44</xref>]. Complementarily, SMPDB enrichment confirmed involvement of beta-alanine, purine, and arachidonic acid metabolism (<xref rid="nutrients-17-02779-f005" ref-type="fig">Figure 5</xref>C), suggesting broader impacts on amino acid turnover and inflammatory responses. Collectively, these findings suggest that OSA starch exerts hepatoprotective effects by orchestrating the gut-derived metabolic networks.</p></sec><sec id="sec3dot6-nutrients-17-02779"><title>3.6. OSA Starch Improves Serum Bile Acid Profiles in ALD Mice</title><p>Untargeted serum metabolomics revealed that OSA starch supplementation significantly remodeled the serum metabolic landscape in ALD mice. PCA illustrated distinct clustering of the Control, Model, and OSA starch groups, indicating that OSA starch markedly shifted the serum metabolome towards a healthier profile (<xref rid="nutrients-17-02779-f006" ref-type="fig">Figure 6</xref>A). Differential analysis between the OSA starch and Model groups identified several metabolites that were significantly altered, particularly those associated with amino acid metabolism and energy balance (<xref rid="nutrients-17-02779-f006" ref-type="fig">Figure 6</xref>B). Key metabolites such as lactic acid, L-glutamic acid, beta-leucine, creatine, and propionyl-L-carnitine showed substantial reductions following OSA starch intervention, suggesting improved mitochondrial function and reduced metabolic stress [<xref rid="B45-nutrients-17-02779" ref-type="bibr">45</xref>].</p><p>Heatmap visualization further highlighted that OSA starch restored the serum levels of these representative metabolites (<xref rid="nutrients-17-02779-f006" ref-type="fig">Figure 6</xref>D). The reduction in lactic acid and glutamic acid implies mitigation of anaerobic glycolysis and excitotoxicity, respectively, both of which are aggravated in liver disease [<xref rid="B46-nutrients-17-02779" ref-type="bibr">46</xref>,<xref rid="B47-nutrients-17-02779" ref-type="bibr">47</xref>]. Additionally, the decrease in beta-leucine and propionyl-L-carnitine may reflect a normalization of branched-chain amino acid metabolism and fatty acid oxidation, respectively, further indicating metabolic reprogramming favoring hepatic health [<xref rid="B48-nutrients-17-02779" ref-type="bibr">48</xref>]. These findings are consistent with previous reports where targeting amino acid and lipid metabolism alleviated liver injury and improved metabolic resilience [<xref rid="B18-nutrients-17-02779" ref-type="bibr">18</xref>]. Overall, the serum metabolomic data support the hypothesis that OSA starch exerts protective effects against ALD by rebalancing energy production.</p></sec><sec id="sec3dot7-nutrients-17-02779"><title>3.7. OSA Starch Modulates Gut Microbiota&#8211;Metabolite&#8211;Host Axis to Alleviate ALD</title><p>To further elucidate the mechanism underlying the beneficial effects of OSA starch on ALD, a comprehensive multi-layer network was constructed integrating gut microbiota, microbial functions, fecal and serum metabolites, and clinical serum indicators. The interaction network (<xref rid="nutrients-17-02779-f007" ref-type="fig">Figure 7</xref>A) revealed <italic toggle="yes">Faecalibaculum rodentium</italic> and <italic toggle="yes">Bifidobacterium adolescentis</italic> as central bacterial nodes connected to key metabolic pathways, including butanoate and propanoate metabolism, and to signature fecal metabolites such as pyruvate, lactic acid, and 2-hydroxy-butanoic acid. These metabolites exhibited strong links with serum markers like ALT, AST, and TG, suggesting that gut microbial modulation impacts host metabolic health. Additionally, microbial functional pathways including pyruvate and propanoate metabolism were identified as pivotal nodes linking gut microbiota alterations to metabolic outputs, reinforcing the microbiota&#8211;metabolite&#8211;host axis hypothesis.</p><p>A structural equation model (SEM) was constructed using AMOS software version 28 (Armonk, NY, USA) to quantify the direct and indirect pathways involved (<xref rid="nutrients-17-02779-f007" ref-type="fig">Figure 7</xref>B). The final model exhibited good fit to the data, with fit indices of RMSEA = 0.065 and CFI = 0.975, indicating an acceptable model fit. OSA starch positively regulated gut microbiota (path coefficient = 0.45, <italic toggle="yes">p</italic> &lt; 0.01) and microbial functions (0.48, <italic toggle="yes">p</italic> &lt; 0.01), which sequentially affected fecal metabolites (0.53, <italic toggle="yes">p</italic> &lt; 0.01) and serum metabolites (0.41, <italic toggle="yes">p</italic> &lt; 0.05). Both fecal and serum metabolites significantly influenced serum markers (0.51, <italic toggle="yes">p</italic> &lt; 0.01 and 0.44, <italic toggle="yes">p</italic> &lt; 0.05, respectively). OSA starch exhibited a strong negative correlation with ALD progression (&#8722;0.39, <italic toggle="yes">p</italic> &lt; 0.05). These findings suggest that the gut microbiota&#8211;metabolite axis serves as a critical mediator of OSA starch&#8217;s therapeutic benefits in ALD.</p><p>Network and SEM analyses strongly support the hypothesis that OSA starch alleviates ALD by modulating the gut microbiota&#8211;metabolite&#8211;host axis. This central role of the gut microbiota aligns with the protective mechanisms attributed to other prebiotics and dietary fibers in ALD research, such as polysaccharides [<xref rid="B49-nutrients-17-02779" ref-type="bibr">49</xref>]. The unique structure and physical and chemical properties of OSA starch may affect the way this regulatory mechanism is realized, thereby influencing the succession of microorganisms and the availability of ecological niches. This indicates that although the core protective axis (gut&#8211;liver communication) is the common goal, different prebiotic fibers participate in it through subtle mechanisms.</p><p>While these findings show the beneficial effects of OSA starch on the gut&#8211;liver axis in ALD mice, several limitations exist. First, murine models differ from humans in alcohol metabolism and disease progression, limiting translation to human ALD. Second, the 28-day intervention may not reflect long-term OSA starch effects or chronic ALD progression, warranting longer studies. Third, replacing native starch entirely with OSA starch does not mimic typical human diets, suggesting that future studies should examine OSA starch in more complex dietary contexts.</p></sec></sec><sec sec-type="conclusions" id="sec4-nutrients-17-02779"><title>4. Conclusions</title><p>In conclusion, this study suggests that dietary OSA starch may ameliorate alcoholic liver disease by orchestrating a gut microbiota&#8211;metabolite&#8211;host axis. OSA starch selectively enriched beneficial gut microbes such as <italic toggle="yes">Faecalibaculum rodentium</italic> and <italic toggle="yes">Bifidobacterium adolescentis</italic>, which appeared associated with enhanced microbial metabolic functions, including pyruvate, butanoate, and propanoate metabolism. Consistent with this, favorable changes in fecal and serum metabolites (e.g., elevated pyruvate and reduced lactic acid), along with improvements in serum lipid profiles and hepatic injury markers, were observed. Structural equation modeling indicates that OSA starch exerts its protective effects through a multi-level regulatory cascade spanning the gut microbiota, microbial functions, metabolic intermediates, and serum indicators. These findings highlight the potential of OSA starch as a dietary intervention for alcoholic fatty liver disease by modulating the gut&#8211;liver metabolic axis.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-nutrients-17-02779"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/nu17172779/s1">https://www.mdpi.com/article/10.3390/nu17172779/s1</uri>, Figure S1: Key Gut Microbial Metabolic Pathways Modulated by OSA Starch in ALD mice.</p><supplementary-material id="nutrients-17-02779-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nutrients-17-02779-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>C.L. and X.P. designed and performed the experiments, analyzed the data, interpreted the results, and wrote the article. T.L., R.M. and Y.T. designed the experiments, interpreted the results. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>All animal procedures received ethical approval from the Animal Ethics Committee of Jiangnan University (JN. No. 20240930c0641123 (17 July 2025)), following the ARRIVE guidelines for animal research.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The Dataset available on request from the authors.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ALD</td><td align="left" valign="middle" rowspan="1" colspan="1">Alcoholic liver disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OSA</td><td align="left" valign="middle" rowspan="1" colspan="1">Octenyl succinic anhydride</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-nutrients-17-02779"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Man</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L.Q.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W.Y.</given-names></name></person-group><article-title>Immunological mechanisms in steatotic liver diseases an overview and clinical perspectives</article-title><source>Clin. Mol. Hepatol.</source><year>2024</year><volume>30</volume><fpage>620</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.3350/cmh.2024.0315</pub-id><pub-id pub-id-type="pmid">38988278</pub-id><pub-id pub-id-type="pmcid">PMC11540396</pub-id></element-citation></ref><ref id="B2-nutrients-17-02779"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>G.X.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>W.P.</given-names></name></person-group><article-title>Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2018</year><volume>15</volume><fpage>111</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2017.119</pub-id><pub-id pub-id-type="pmid">29018272</pub-id><pub-id pub-id-type="pmcid">PMC5899973</pub-id></element-citation></ref><ref id="B3-nutrients-17-02779"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bajaj</surname><given-names>J.S.</given-names></name></person-group><article-title>Alcohol, liver disease and the gut microbiota</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2019</year><volume>16</volume><fpage>235</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1038/s41575-018-0099-1</pub-id><pub-id pub-id-type="pmid">30643227</pub-id></element-citation></ref><ref id="B4-nutrients-17-02779"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Mu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hao</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.B.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.B.</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>C.R.</given-names></name></person-group><article-title>Propionate Ameliorates Alcohol-Induced Liver Injury in Mice via the Gut-Liver Axis: Focus on the Improvement of Intestinal Permeability</article-title><source>J. Agric. Food Chem.</source><year>2022</year><volume>70</volume><fpage>6084</fpage><lpage>6096</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.2c00633</pub-id><pub-id pub-id-type="pmid">35549256</pub-id></element-citation></ref><ref id="B5-nutrients-17-02779"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Q.X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z.L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>Z.W.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>J.</given-names></name></person-group><article-title>Structural elucidation of a highly branched &#945;-D-glucan from Huangjiu and its hepatoprotective activity via gut microbiome regulation and intestinal barrier repairment</article-title><source>Carbohydr. Polym.</source><year>2024</year><volume>324</volume><fpage>121423</fpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2023.121423</pub-id><pub-id pub-id-type="pmid">37985032</pub-id></element-citation></ref><ref id="B6-nutrients-17-02779"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><name name-style="western"><surname>McClain</surname><given-names>C.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>W.</given-names></name></person-group><article-title>Microbiome dysbiosis and alcoholic liver disease</article-title><source>Liver Res.</source><year>2019</year><volume>3</volume><fpage>218</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.livres.2019.09.001</pub-id><pub-id pub-id-type="pmid">33868760</pub-id><pub-id pub-id-type="pmcid">PMC8048700</pub-id></element-citation></ref><ref id="B7-nutrients-17-02779"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bluemel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Kuelbs</surname><given-names>C.</given-names></name><name name-style="western"><surname>Moncera</surname><given-names>K.</given-names></name><name name-style="western"><surname>Torralba</surname><given-names>M.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Fouts</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Schnabl</surname><given-names>B.</given-names></name></person-group><article-title>Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice</article-title><source>Gut Microbes</source><year>2020</year><volume>11</volume><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1080/19490976.2019.1595300</pub-id><pub-id pub-id-type="pmid">30982395</pub-id><pub-id pub-id-type="pmcid">PMC7524386</pub-id></element-citation></ref><ref id="B8-nutrients-17-02779"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z.M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>T.T.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name></person-group><article-title>Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease</article-title><source>Gut Microbes</source><year>2025</year><volume>17</volume><fpage>2500099</fpage><pub-id pub-id-type="doi">10.1080/19490976.2025.2500099</pub-id><pub-id pub-id-type="pmid">40394806</pub-id><pub-id pub-id-type="pmcid">PMC12101596</pub-id></element-citation></ref><ref id="B9-nutrients-17-02779"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Z.Y.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y.Q.</given-names></name></person-group><article-title>Insights into the structural, morphological, and thermal property changes in simulated digestion and fermentability of four resistant starches from high amylose maize starch</article-title><source>Food Hydrocoll.</source><year>2023</year><volume>142</volume><fpage>108770</fpage><pub-id pub-id-type="doi">10.1016/j.foodhyd.2023.108770</pub-id></element-citation></ref><ref id="B10-nutrients-17-02779"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Z.Y.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y.Q.</given-names></name></person-group><article-title>Recrystallized Resistant Starch: Structural Changes in the Stomach, Duodenum, and Ileum and the Impact on Blood Glucose and Intestinal Microbiome in Mice</article-title><source>J. Agric. Food Chem.</source><year>2023</year><volume>71</volume><fpage>12080</fpage><lpage>12093</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.3c02290</pub-id><pub-id pub-id-type="pmid">37507341</pub-id></element-citation></ref><ref id="B11-nutrients-17-02779"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.X.E.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.Y.</given-names></name></person-group><article-title>Structure properties of Canna edulis RS3 (double enzyme hydrolysis) and RS4 (OS-starch and cross-linked starch): Influence on fermentation products and human gut microbiota</article-title><source>Int. J. Biol. Macromol.</source><year>2024</year><volume>265</volume><elocation-id>130700</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.130700</pub-id><pub-id pub-id-type="pmid">38458281</pub-id></element-citation></ref><ref id="B12-nutrients-17-02779"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F.W.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>W.R.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>H.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Y.L.</given-names></name></person-group><article-title>Role of the gut microbiota in dietary patterns rich in torularhodin OSA colon-targeted delivery</article-title><source>Food Funct.</source><year>2022</year><volume>13</volume><fpage>11034</fpage><lpage>11048</lpage><pub-id pub-id-type="doi">10.1039/D2FO01901A</pub-id><pub-id pub-id-type="pmid">36193807</pub-id></element-citation></ref><ref id="B13-nutrients-17-02779"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devarakonda</surname><given-names>S.L.S.</given-names></name><name name-style="western"><surname>Superdock</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J.N.F.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Loinard-Gonz&#225;lez</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Poole</surname><given-names>A.C.</given-names></name></person-group><article-title>Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation</article-title><source>Gut Microbes</source><year>2024</year><volume>16</volume><fpage>2367301</fpage><pub-id pub-id-type="doi">10.1080/19490976.2024.2367301</pub-id><pub-id pub-id-type="pmid">38913541</pub-id><pub-id pub-id-type="pmcid">PMC11197919</pub-id></element-citation></ref><ref id="B14-nutrients-17-02779"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huicui</surname><given-names>L.</given-names></name><name name-style="western"><surname>Min</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Qingyu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Baoming</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chenxi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhifei</surname><given-names>C.</given-names></name><name name-style="western"><surname>Juxiu</surname><given-names>L.</given-names></name></person-group><article-title>Health beneficial effects of resistant starch on diabetes and obesity via regulation of gut microbiota: A review</article-title><source>Food Funct.</source><year>2020</year><volume>11</volume><fpage>5749</fpage><lpage>5767</lpage><pub-id pub-id-type="doi">10.1039/d0fo00855a</pub-id><pub-id pub-id-type="pmid">32602874</pub-id></element-citation></ref><ref id="B15-nutrients-17-02779"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Z.H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y.C.</given-names></name></person-group><article-title>Distribution of octenylsuccinate substituents within a single granule of modified waxy maize starch determined by Raman microspectroscopy</article-title><source>Carbohydr. Polym.</source><year>2019</year><volume>216</volume><fpage>282</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2019.04.034</pub-id><pub-id pub-id-type="pmid">31047068</pub-id></element-citation></ref><ref id="B16-nutrients-17-02779"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Maierheba</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F.Z.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Z.X.</given-names></name><etal/></person-group><article-title>Octenyl Succinic Anhydride-Modified Starch Attenuates Body Weight Gain and Changes Intestinal Environment of High-Fat Diet-Fed Mice</article-title><source>Foods</source><year>2022</year><volume>11</volume><elocation-id>2980</elocation-id><pub-id pub-id-type="doi">10.3390/foods11192980</pub-id><pub-id pub-id-type="pmid">36230056</pub-id><pub-id pub-id-type="pmcid">PMC9563757</pub-id></element-citation></ref><ref id="B17-nutrients-17-02779"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>Y.Q.</given-names></name><name name-style="western"><surname>Kovatcheva-Datchary</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.B.</given-names></name><etal/></person-group><article-title>Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota</article-title><source>Nat. Metab.</source><year>2024</year><volume>6</volume><fpage>578</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1038/s42255-024-00988-y</pub-id><pub-id pub-id-type="pmid">38409604</pub-id><pub-id pub-id-type="pmcid">PMC10963277</pub-id></element-citation></ref><ref id="B18-nutrients-17-02779"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ni</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>L.</given-names></name><name name-style="western"><surname>Siliceo</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Long</surname><given-names>X.</given-names></name><name name-style="western"><surname>Nychas</surname><given-names>E.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ismaiah</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Leung</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations</article-title><source>Cell Metab.</source><year>2023</year><volume>35</volume><fpage>1530</fpage><lpage>1547</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2023.08.002</pub-id><pub-id pub-id-type="pmid">37673036</pub-id></element-citation></ref><ref id="B19-nutrients-17-02779"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>X.H.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>W.Y.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y.Q.</given-names></name></person-group><article-title>Esterified starches enhance short-term satiety in mice structural and physicochemical alterations</article-title><source>Food Funct.</source><year>2024</year><volume>15</volume><fpage>12058</fpage><lpage>12068</lpage><pub-id pub-id-type="doi">10.1039/D4FO04174G</pub-id><pub-id pub-id-type="pmid">39564801</pub-id></element-citation></ref><ref id="B20-nutrients-17-02779"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ewald</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hacariz</surname><given-names>O.</given-names></name><name name-style="western"><surname>Basu</surname><given-names>N.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>J.</given-names></name></person-group><article-title>Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data</article-title><source>Nat. Protoc.</source><year>2022</year><volume>17</volume><fpage>1735</fpage><lpage>1761</lpage><pub-id pub-id-type="doi">10.1038/s41596-022-00710-w</pub-id><pub-id pub-id-type="pmid">35715522</pub-id></element-citation></ref><ref id="B21-nutrients-17-02779"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Youn</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Baik</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Chae</surname><given-names>H.W.</given-names></name></person-group><article-title>Optimal cutoffs of fatty liver index and hepatic steatosis index in diagnosing pediatric MASLD</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2025</year><volume>25</volume><fpage>00530</fpage><pub-id pub-id-type="doi">10.1016/j.cgh.2025.06.011</pub-id><pub-id pub-id-type="pmid">40582390</pub-id></element-citation></ref><ref id="B22-nutrients-17-02779"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abeysekera</surname><given-names>K.W.A.</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Hammerton</surname><given-names>G.</given-names></name><name name-style="western"><surname>Portal</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>F.H.</given-names></name><name name-style="western"><surname>Heron</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hickman</surname><given-names>M.</given-names></name></person-group><article-title>Prevalence of steatosis and fibrosis in young adults in the UK: A population-based study</article-title><source>Lancet Gastroenterol.</source><year>2020</year><volume>5</volume><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(19)30419-4</pub-id><pub-id pub-id-type="pmid">31954687</pub-id><pub-id pub-id-type="pmcid">PMC7026693</pub-id></element-citation></ref><ref id="B23-nutrients-17-02779"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.R.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D.Q.</given-names></name><name name-style="western"><surname>Shu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>L.X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>K.C.</given-names></name><etal/></person-group><article-title>Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification</article-title><source>Cell Host Microbe</source><year>2024</year><volume>32</volume><fpage>1331</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2024.06.008</pub-id><pub-id pub-id-type="pmid">38959900</pub-id></element-citation></ref><ref id="B24-nutrients-17-02779"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.J.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>X.D.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X.L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Shang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>G.F.</given-names></name><etal/></person-group><article-title>Liver-specific inactivation of Cideb improves metabolic profiles and ameliorates steatohepatitis and fibrosis in animal models for MASH</article-title><source>Pharmacol. Res.</source><year>2025</year><volume>214</volume><fpage>107664</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2025.107664</pub-id><pub-id pub-id-type="pmid">39984006</pub-id></element-citation></ref><ref id="B25-nutrients-17-02779"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hersberger</surname><given-names>M.</given-names></name><name name-style="western"><surname>von Eckardstein</surname><given-names>A.</given-names></name></person-group><article-title>Low high-density lipoprotein cholesterol&#8212;Physiological background, clinical importance and drug treatment</article-title><source>Drugs</source><year>2003</year><volume>63</volume><fpage>1907</fpage><lpage>1945</lpage><pub-id pub-id-type="doi">10.2165/00003495-200363180-00003</pub-id><pub-id pub-id-type="pmid">12930163</pub-id></element-citation></ref><ref id="B26-nutrients-17-02779"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsiavos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Antza</surname><given-names>C.</given-names></name><name name-style="western"><surname>Trakatelli</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kotsis</surname><given-names>V.</given-names></name></person-group><article-title>The Microbial Perspective: A Systematic Literature Review on Hypertension and Gut Microbiota</article-title><source>Nutrients</source><year>2024</year><volume>16</volume><elocation-id>3698</elocation-id><pub-id pub-id-type="doi">10.3390/nu16213698</pub-id><pub-id pub-id-type="pmid">39519531</pub-id><pub-id pub-id-type="pmcid">PMC11547301</pub-id></element-citation></ref><ref id="B27-nutrients-17-02779"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>R.Q.</given-names></name><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X.</given-names></name><name name-style="western"><surname>Schnabl</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tilg</surname><given-names>H.</given-names></name></person-group><article-title>Gut microbiome, liver immunology, and liver diseases</article-title><source>Cell. Mol. Immunol.</source><year>2021</year><volume>18</volume><fpage>4</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1038/s41423-020-00592-6</pub-id><pub-id pub-id-type="pmid">33318628</pub-id><pub-id pub-id-type="pmcid">PMC7852541</pub-id></element-citation></ref><ref id="B28-nutrients-17-02779"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Zou</surname><given-names>Y.X.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Y.H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>An</surname><given-names>X.F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.Y.</given-names></name></person-group><article-title>Host Gasdermin D restrains systemic endotoxemia by capturing Proteobacteria in the colon of high-fat diet-feeding mice</article-title><source>Gut Microbes</source><year>2021</year><volume>13</volume><fpage>1946369</fpage><pub-id pub-id-type="doi">10.1080/19490976.2021.1946369</pub-id><pub-id pub-id-type="pmid">34275417</pub-id><pub-id pub-id-type="pmcid">PMC8288038</pub-id></element-citation></ref><ref id="B29-nutrients-17-02779"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeMinicis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rychlicki</surname><given-names>C.</given-names></name><name name-style="western"><surname>Agostinelli</surname><given-names>L.</given-names></name><name name-style="western"><surname>Saccomanno</surname><given-names>S.</given-names></name><name name-style="western"><surname>Candelaresi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Trozzi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Mingarelli</surname><given-names>E.</given-names></name><name name-style="western"><surname>Facinelli</surname><given-names>B.</given-names></name><name name-style="western"><surname>Magi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Palmieri</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in Mice</article-title><source>Hepatology</source><year>2014</year><volume>59</volume><fpage>1738</fpage><lpage>1749</lpage><pub-id pub-id-type="doi">10.1002/hep.26695</pub-id><pub-id pub-id-type="pmid">23959503</pub-id></element-citation></ref><ref id="B30-nutrients-17-02779"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobranowski</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Stintzi</surname><given-names>A.</given-names></name></person-group><article-title>Resistant starch, microbiome, and precision modulation</article-title><source>Gut Microbes</source><year>2021</year><volume>13</volume><fpage>1926842</fpage><pub-id pub-id-type="doi">10.1080/19490976.2021.1926842</pub-id><pub-id pub-id-type="pmid">34275431</pub-id><pub-id pub-id-type="pmcid">PMC8288039</pub-id></element-citation></ref><ref id="B31-nutrients-17-02779"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olagunju</surname><given-names>A.</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kenny</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gideon</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mookadam</surname><given-names>F.</given-names></name><name name-style="western"><surname>Unzek</surname><given-names>S.</given-names></name></person-group><article-title>Virulent endocarditis due to Haemophilus parainfluenzae: A systematic review of the literature</article-title><source>World J. Cardiol.</source><year>2022</year><volume>14</volume><fpage>546</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.4330/wjc.v14.i10.546</pub-id><pub-id pub-id-type="pmid">36339888</pub-id><pub-id pub-id-type="pmcid">PMC9627352</pub-id></element-citation></ref><ref id="B32-nutrients-17-02779"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leibovitzh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nayeri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Borowski</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hernandez-Rocha</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Turpin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Stempak</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Sandhu</surname><given-names>I.</given-names></name><name name-style="western"><surname>Milgrom</surname><given-names>R.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile</article-title><source>J. Crohn&#8217;s Colitis</source><year>2024</year><volume>18</volume><fpage>1957</fpage><lpage>1966</lpage><pub-id pub-id-type="doi">10.1093/ecco-jcc/jjae096</pub-id><pub-id pub-id-type="pmid">38980940</pub-id><pub-id pub-id-type="pmcid">PMC11637524</pub-id></element-citation></ref><ref id="B33-nutrients-17-02779"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rios-Covian</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gueimonde</surname><given-names>M.</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Flint</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>de los Reyes-Gavilan</surname><given-names>C.G.</given-names></name></person-group><article-title>Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis</article-title><source>FEMS Microbiol. Lett.</source><year>2015</year><volume>362</volume><elocation-id>176</elocation-id><pub-id pub-id-type="doi">10.1093/femsle/fnv176</pub-id><pub-id pub-id-type="pmid">26420851</pub-id></element-citation></ref><ref id="B34-nutrients-17-02779"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zagato</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pozzi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bertocchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schioppa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Saccheri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Guglietta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fosso</surname><given-names>B.</given-names></name><name name-style="western"><surname>Melocchi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nizzoli</surname><given-names>G.</given-names></name><name name-style="western"><surname>Troisi</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth</article-title><source>Nat. Microbiol.</source><year>2020</year><volume>5</volume><fpage>511</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0649-5</pub-id><pub-id pub-id-type="pmid">31988379</pub-id><pub-id pub-id-type="pmcid">PMC7048616</pub-id></element-citation></ref><ref id="B35-nutrients-17-02779"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawano</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>M.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.M.</given-names></name><name name-style="western"><surname>Bilate</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Araujo</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>Tanoue</surname><given-names>T.</given-names></name><name name-style="western"><surname>Atarashi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ladinsky</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Reiner</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.H.</given-names></name><etal/></person-group><article-title>Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome</article-title><source>Cell</source><year>2022</year><volume>185</volume><fpage>3501</fpage><lpage>3519</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.08.005</pub-id><pub-id pub-id-type="pmid">36041436</pub-id><pub-id pub-id-type="pmcid">PMC9556172</pub-id></element-citation></ref><ref id="B36-nutrients-17-02779"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shirakawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Masuda</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>H.</given-names></name><name name-style="western"><surname>Iijima</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yoshikawa</surname><given-names>N.</given-names></name></person-group><article-title>antigen and antibody in children with IgA nephropathy and Henoch-Schonlein nephritis</article-title><source>Am. J. Kidney Dis.</source><year>2000</year><volume>36</volume><fpage>47</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1053/ajkd.2000.8264</pub-id><pub-id pub-id-type="pmid">10873871</pub-id></element-citation></ref><ref id="B37-nutrients-17-02779"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>W.N.</given-names></name><name name-style="western"><surname>Shang</surname><given-names>H.Y.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z.Y.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>Y.F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.R.</given-names></name></person-group><article-title>Green Radish Polysaccharide Prevents Alcoholic Liver Injury by Interfering with Intestinal Bacteria and Short-Chain Fatty Acids in Mice</article-title><source>Foods</source><year>2024</year><volume>13</volume><elocation-id>3733</elocation-id><pub-id pub-id-type="doi">10.3390/foods13233733</pub-id><pub-id pub-id-type="pmid">39682806</pub-id><pub-id pub-id-type="pmcid">PMC11639836</pub-id></element-citation></ref><ref id="B38-nutrients-17-02779"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yiew</surname><given-names>N.K.H.</given-names></name><name name-style="western"><surname>Vazquez</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Martino</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Kennon-McGill</surname><given-names>S.</given-names></name><name name-style="western"><surname>Price</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Allard</surname><given-names>F.D.</given-names></name><name name-style="western"><surname>Yee</surname><given-names>E.U.</given-names></name><name name-style="western"><surname>Layman</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>James</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>Mccommis</surname><given-names>K.S.</given-names></name><etal/></person-group><article-title>Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult</article-title><source>Mol. Metab.</source><year>2023</year><volume>77</volume><fpage>101808</fpage><pub-id pub-id-type="doi">10.1016/j.molmet.2023.101808</pub-id><pub-id pub-id-type="pmid">37716594</pub-id><pub-id pub-id-type="pmcid">PMC10561123</pub-id></element-citation></ref><ref id="B39-nutrients-17-02779"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dean</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>L.</given-names></name><name name-style="western"><surname>Beaven</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tontonoz</surname><given-names>P.</given-names></name><name name-style="western"><surname>Reue</surname><given-names>K.</given-names></name><name name-style="western"><surname>Dipple</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>J.C.</given-names></name></person-group><article-title>Resistance to Diet-Induced Obesity in Mice with Synthetic Glyoxylate Shunt</article-title><source>Cell Metab.</source><year>2009</year><volume>9</volume><fpage>525</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2009.04.008</pub-id><pub-id pub-id-type="pmid">19490907</pub-id><pub-id pub-id-type="pmcid">PMC4277884</pub-id></element-citation></ref><ref id="B40-nutrients-17-02779"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Recharla</surname><given-names>N.</given-names></name><name name-style="western"><surname>Geesala</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X.Z.</given-names></name></person-group><article-title>Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><elocation-id>2275</elocation-id><pub-id pub-id-type="doi">10.3390/nu15102275</pub-id><pub-id pub-id-type="pmid">37242159</pub-id><pub-id pub-id-type="pmcid">PMC10221771</pub-id></element-citation></ref><ref id="B41-nutrients-17-02779"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cani</surname><given-names>P.D.</given-names></name></person-group><article-title>Is colonic propionate delivery a novel solution to improve metabolism and inflammation in overweight or obese subjects?</article-title><source>Gut</source><year>2019</year><volume>68</volume><fpage>1352</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2019-318776</pub-id><pub-id pub-id-type="pmid">31028156</pub-id><pub-id pub-id-type="pmcid">PMC6691852</pub-id></element-citation></ref><ref id="B42-nutrients-17-02779"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.T.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>Y.K.</given-names></name><name name-style="western"><surname>Zou</surname><given-names>Y.F.</given-names></name><name name-style="western"><surname>Han</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Pu</surname><given-names>J.Z.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>J.Q.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H.B.</given-names></name></person-group><article-title>Linking Microbial Functional Gene Abundance and Daqu Extracellular Enzyme Activity: Implications for Carbon Metabolism during Fermentation</article-title><source>Foods</source><year>2022</year><volume>11</volume><elocation-id>3623</elocation-id><pub-id pub-id-type="doi">10.3390/foods11223623</pub-id><pub-id pub-id-type="pmid">36429214</pub-id><pub-id pub-id-type="pmcid">PMC9689858</pub-id></element-citation></ref><ref id="B43-nutrients-17-02779"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deja</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Kucejova</surname><given-names>B.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X.R.</given-names></name><name name-style="western"><surname>Mizerska</surname><given-names>M.</given-names></name><name name-style="western"><surname>Villegas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pudelko-Malik</surname><given-names>N.</given-names></name><name name-style="western"><surname>Browder</surname><given-names>N.</given-names></name><name name-style="western"><surname>Inigo-Vollmer</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability</article-title><source>Cell Metab.</source><year>2024</year><volume>36</volume><fpage>1088</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2024.02.004</pub-id><pub-id pub-id-type="pmid">38447582</pub-id><pub-id pub-id-type="pmcid">PMC11081827</pub-id></element-citation></ref><ref id="B44-nutrients-17-02779"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Q.X.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X.Y.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Q.M.</given-names></name><name name-style="western"><surname>Su</surname><given-names>Y.S.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>Q.F.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>Z.Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Tryptophan metabolism in health and disease</article-title><source>Cell Metab.</source><year>2023</year><volume>35</volume><fpage>1304</fpage><lpage>1326</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2023.06.004</pub-id><pub-id pub-id-type="pmid">37352864</pub-id></element-citation></ref><ref id="B45-nutrients-17-02779"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>McGinnis</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Michel</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Marentette</surname><given-names>J.O.</given-names></name><name name-style="western"><surname>Reisdorph</surname><given-names>R.</given-names></name><name name-style="western"><surname>Roede</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Fritz</surname><given-names>K.S.</given-names></name></person-group><article-title>Click chemistry-based thiol redox proteomics reveals significant cysteine reduction induced by chronic ethanol consumption</article-title><source>Redox Biol.</source><year>2023</year><volume>64</volume><elocation-id>102792</elocation-id><pub-id pub-id-type="doi">10.1016/j.redox.2023.102792</pub-id><pub-id pub-id-type="pmid">37390786</pub-id><pub-id pub-id-type="pmcid">PMC10331594</pub-id></element-citation></ref><ref id="B46-nutrients-17-02779"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puhakka</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>H.</given-names></name><name name-style="western"><surname>Haikonen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Leclercq</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hanhineva</surname><given-names>K.</given-names></name><name name-style="western"><surname>Maccioni</surname><given-names>L.</given-names></name><name name-style="western"><surname>Amadieu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lehtonen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Maennistoe</surname><given-names>V.</given-names></name><name name-style="western"><surname>Rysae</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Serum Metabolite Profile in Progressive Versus Nonprogressive Alcohol-Related Liver Disease: A Cross-Sectional Metabolomics Study</article-title><source>Liver Int.</source><year>2025</year><volume>45</volume><fpage>70128</fpage><pub-id pub-id-type="doi">10.1111/liv.70128</pub-id><pub-id pub-id-type="pmcid">PMC12070861</pub-id><pub-id pub-id-type="pmid">40358071</pub-id></element-citation></ref><ref id="B47-nutrients-17-02779"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X.P.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Q.X.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Aleteng</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people</article-title><source>Hepatol. Int.</source><year>2023</year><volume>17</volume><fpage>313</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1007/s12072-022-10439-z</pub-id><pub-id pub-id-type="pmid">36327053</pub-id></element-citation></ref><ref id="B48-nutrients-17-02779"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Okabe</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chiba</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hui</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Eguchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Iwasa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ito</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Branched-chain amino acids and l-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liver</article-title><source>Biomed. Pharmacother.</source><year>2021</year><volume>135</volume><elocation-id>111181</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2020.111181</pub-id><pub-id pub-id-type="pmid">33395607</pub-id></element-citation></ref><ref id="B49-nutrients-17-02779"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>W.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>F.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name></person-group><article-title>Glucopyranose from Pleurotus geesteranus prevent alcoholic liver diseases by regulating Nrf2/HO-1-TLR4/NF-&#954;B signalling pathways and gut microbiota</article-title><source>Food Funct.</source><year>2022</year><volume>13</volume><fpage>2441</fpage><lpage>2455</lpage><pub-id pub-id-type="doi">10.1039/D1FO03486C</pub-id><pub-id pub-id-type="pmid">35048917</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="nutrients-17-02779-f001" orientation="portrait"><label>Figure 1</label><caption><p>OSA starch ameliorates hepatic injury and lipid dysregulation in AL mice. (<bold>A</bold>) Schematic representation of the experimental protocol. (<bold>B</bold>) Liver index. (<bold>C</bold>,<bold>D</bold>) Serum ALT and AST levels. (<bold>E</bold>,<bold>F</bold>) Serum TC and TG levels. (<bold>G</bold>,<bold>H</bold>) Serum HDL-C and LDL-C levels. (<bold>I</bold>) Representative liver histology with H&amp;E staining. Data are presented as mean &#177; SD (n = 8). Statistical significance was determined by one-way ANOVA with Dunnett&#8217;s post hoc test: ns, not significant <italic toggle="yes">p</italic> &gt; 0.05, * <italic toggle="yes">p</italic> &lt; 0.05, ** <italic toggle="yes">p</italic> &lt; 0.01.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02779-g001.jpg"/></fig><fig position="float" id="nutrients-17-02779-f002" orientation="portrait"><label>Figure 2</label><caption><p>OSA starch intervention reshapes gut microbiota composition in ALD mice. (<bold>A</bold>) Alpha diversity indices&#8212;Shannon. (<bold>B</bold>) PCA based on Bray&#8211;Curtis dissimilarity reveals distinct clustering. (<bold>C</bold>) Gut microbiota composition at the phylum level. (<bold>D</bold>) Gut microbiota composition at the species level.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02779-g002.jpg"/></fig><fig position="float" id="nutrients-17-02779-f003" orientation="portrait"><label>Figure 3</label><caption><p>OSA starch modulates key gut microbial taxa and their functional profiles in ALD mice. (<bold>A</bold>) LEfSe cladogram and LDA score of differential species. (<bold>B</bold>) Random forest classification error rates for overall and individual groups. (<bold>C</bold>) Top microbial features ranked by mean decrease accuracy contributing to group discrimination. (<bold>D</bold>) Co-occurrence network of differential gut microbes colored by group prevalence. (<bold>E</bold>) Predicted KEGG metabolic pathways (Level 3) of gut microbiota across groups.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02779-g003.jpg"/></fig><fig position="float" id="nutrients-17-02779-f004" orientation="portrait"><label>Figure 4</label><caption><p>OSA starch reshapes the fecal metabolome in ALD mice. (<bold>A</bold>) PCA score plot of fecal metabolome showing group separation. (<bold>B</bold>) Volcano plot of differential metabolites between Control and Model groups. (<bold>C</bold>) Volcano plot of differential metabolites between OSA starch and Model groups. (<bold>D</bold>) Upset plot indicating metabolite overlap among four key pathways (pyruvate, propanoate, butanoate, glyoxylate/dicarboxylate metabolism). (<bold>E</bold>) Heatmap of representative differential metabolites across groups.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02779-g004.jpg"/></fig><fig position="float" id="nutrients-17-02779-f005" orientation="portrait"><label>Figure 5</label><caption><p>OSA starch modulates key metabolic pathways in ALD mice. (<bold>A</bold>) Metabolite&#8211;Pathway network connecting key metabolites to their respective metabolic pathways. Blue represents metabolic pathways, and green represents metabolic metabolites. (<bold>B</bold>) KEGG pathway enrichment analysis of altered metabolites (<italic toggle="yes">p</italic> &lt; 0.01). (<bold>C</bold>) SMPDB pathway enrichment analysis of altered metabolites (<italic toggle="yes">p</italic> &lt; 0.01). Red represents altered metabolic pathways in KEGG Database and SMPDB database, respectively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02779-g005.jpg"/></fig><fig position="float" id="nutrients-17-02779-f006" orientation="portrait"><label>Figure 6</label><caption><p>OSA starch improves serum metabolism profiles in ALD mice. (<bold>A</bold>) PCA based on untargeted serum metabolomics. (<bold>B</bold>) Volcano plot of differentially expressed serum metabolites between the Control and Model groups. (<bold>C</bold>) Volcano plot of differentially expressed serum metabolites between OSA starch and Model groups. (<bold>D</bold>) Heatmap showing the relative abundance of significantly altered metabolites.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02779-g006.jpg"/></fig><fig position="float" id="nutrients-17-02779-f007" orientation="portrait"><label>Figure 7</label><caption><p>OSA starch modulates gut microbiota&#8211;metabolite&#8211;host axis to alleviate ALD. (<bold>A</bold>) Interaction network depicting relationships among gut microbiota, microbial metabolism, fecal metabolites, serum metabolites, and serum indicators. (<bold>B</bold>) SEM illustrating the pathways from OSA starch intervention through gut microbiota, microbial functions, fecal and serum metabolites, and serum markers to alcoholic liver disease outcome. * <italic toggle="yes">p</italic> &lt; 0.05, ** <italic toggle="yes">p</italic> &lt; 0.01.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02779-g007.jpg"/></fig></floats-group></article></pmc-articleset>